Patient Perspectives on Managing Adverse Effects from Capecitabine, Trastuzumab, and Tucatinib
Panelists discuss the adverse effects experienced by a patient undergoing treatment with capecitabine (Xeloda), trastuzumab (Herceptin), and tucatinib (Tukysa), along with the strategies employed to manage those adverse effects, while also addressing patient follow-up procedures, including the frequency of visits, typical labs and imaging ordered, concerning symptoms and lab results, and the outcomes of the patient's most recent follow-up appointment.
- Dr Iyengar asks Dorian Nygard: What side adverse effects have you experienced with your current treatment (capecitabine [Zeloda], trastuzumab [Herceptin], and tucatinib [Tukysa])?
- What strategies have you found to be most helpful in managing these side adverse effects?
- Dr Iyengar asks Odessa Williams: Describe patient follow-up procedures in your practice.
- How often do you see your patients for follow-up at your institution
- What labs and imaging are typically ordered and at what frequency?
- During follow-up, what symptoms or labs are most concerning to you?
- Dr Iyengar asks Dorian Nygard: What was the outcome of your most recent follow-up appointment?
Recent Videos
Related Content
